14 research outputs found

    Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer

    No full text
    <p><b>Introduction:</b> Prostate specific membrane antigen (PSMA) has become an attractive diagnostic and therapeutic target for small molecule ligands. Radionuclide-chelating ligands can be labeled with either <sup>68</sup>Ga for positron-emission-tomography (PET) or <sup>177</sup>Lu for radionuclide therapy.</p> <p><b>Areas covered:</b> In this literature review we evaluate the diagnostic value of <sup>68</sup>Ga PSMA PET/CT and the therapeutic potential of <sup>177</sup>Lu PSMA radioligand therapy (RLT) in patients with prostate cancer. <sup>68</sup>Ga PSMA PET/CT is more accurate than CT for nodal staging and superior to conventional imaging in patients with biochemical recurrence, translating into major changes in clinical management. The preliminary data for <sup>177</sup>Lu PSMA indicates >50% reduction of PSA levels in up to 59% of patients. Severe adverse events occurred <10% of patients after RLT.</p> <p><b>Expert commentary:</b> PSMA ligands for diagnostic and therapeutic purpose will significantly impact the management of patients with prostate cancer.</p

    A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images

    No full text
    <div><p>Textural analysis might give new insights into the quantitative characterization of metabolically active tumors. More than thirty textural parameters have been investigated in former F18-FDG studies already. The purpose of the paper is to declare basic requirements as a selection strategy to identify the most appropriate heterogeneity parameters to measure textural features. Our predefined requirements were: a reliable heterogeneity parameter has to be volume independent, reproducible, and suitable for expressing quantitatively the degree of heterogeneity. Based on this criteria, we compared various suggested measures of homogeneity. A homogeneous cylindrical phantom was measured on three different PET/CT scanners using the commonly used protocol. In addition, a custom-made inhomogeneous tumor insert placed into the NEMA image quality phantom was imaged with a set of acquisition times and several different reconstruction protocols. PET data of 65 patients with proven lung lesions were retrospectively analyzed as well. Four heterogeneity parameters out of 27 were found as the most attractive ones to characterize the textural properties of metabolically active tumors in FDG PET images. These four parameters included Entropy, Contrast, Correlation, and Coefficient of Variation. These parameters were independent of delineated tumor volume (bigger than 25–30 ml), provided reproducible values (relative standard deviation< 10%), and showed high sensitivity to changes in heterogeneity. Phantom measurements are a viable way to test the reliability of heterogeneity parameters that would be of interest to nuclear imaging clinicians.</p></div

    Representative volume dependence of four different HePs.

    No full text
    <p>Phantom data points (“Ph.Data”) measured on three different scanners are differentiated by continuous color lines. Individual data points calculated from human lung lesions are displayed as the individual purple dots (“Hu.Data”). The volume dependence of the all investigated parameters can be found in the Supplemental Material.</p

    Reproducibility of the 8 remaining HePs (see Table 3, type A), as the function of reconstruction settings (see in Table 1) and acquisition time.

    No full text
    <p>Reproducibility of the 8 remaining HePs (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0164113#pone.0164113.t003" target="_blank">Table 3</a>, type A), as the function of reconstruction settings (see in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0164113#pone.0164113.t001" target="_blank">Table 1</a>) and acquisition time.</p
    corecore